Y-mAbs Therapeutics, Inc (NASDAQ:YMAB)

32.97
Delayed Data
As of Jan 17
 +0.35 / +1.07%
Today’s Change
18.60
Today|||52-Week Range
34.49
+5.50%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Wedell Wedellsborg Johan Ernst
Director
Sale8/20/2019108,128$27.42$3.0M+21.17%
Sofinnova Ventures Inc
Director
Buy10/30/201990,000$28.00$2.5M+14.72%
Wedell Wedellsborg Johan Ernst
Director
Sale8/29/201989,066$26.58$2.4M+21.89%
Wedell Wedellsborg Johan Ernst
Director
Sale8/21/201960,116$27.83$1.7M+18.30%
Wedell Wedellsborg Johan Ernst
Director
Sale9/05/201911,452$27.00$309.2K+23.81%
Wedell Wedellsborg Johan Ernst
Director
Sale9/06/20195,791$27.00$156.4K+20.59%
Gad Thomas
Chairman & President
Sale12/02/20194,000$32.48$129.9K+1.89%
Gad Thomas
Chairman & President
Sale12/16/20194,000$31.54$126.2K+5.17%
Gad Thomas
Chairman & President
Sale5/13/20196,000$20.61$123.7K+62.81%
Gad Thomas
Chairman & President
Sale1/13/20204,000$30.90$123.6K+6.39%
Page of 3